Purchase by Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Kiselak Tomas, Harwin Peter Evan
CRESCENT BIOPHARMA, INC.
Transaction date
- Shares
- 525,897
- Price per share
-
14.50
Reported 14.499
People / SEC CIK 0001769651
Insider transactions reported to the SEC
Browse linked events from SEC filings within FilingRelay's coverage.
Allow Google Analytics to measure visits and clicks on SEC source links. You can change your choice at any time.